Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine + Lispro vs NPH + Regular in T1DM
NCT00537251Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2001
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Nov 2001; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00537251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537251.